The US Treasury retained its previous guidance for future debt issuance, signaling no change in note and bond auction sizes well into 2027. The quarterly refunding will raise about $28.7 billion in new cash. Auctions will be held on August 11, 12 and 13. Bloomberg's Michael McKee reports.
US private payrolls rose 44,000 in July after a revised 95,000 increase in the prior month as companies added fewer jobs than expected, according to ADP Research data out Wednesday. Michael McKee reports on Bloomberg Television.
Joint US-Japan intervention has helped the yen for now, but isn't a game-changer for the currency or the economy, Japan's former Prime Minister Fumio Kishida said in a Bloomberg TV interview in Tokyo. He touted a ¥370 trillion ($2.3 trillion) growth strategy as the long-term vision that will transform Japan's fortunes.
Ariana Salvatore, head of US public policy strategy at Morgan Stanley, says a win by progressive Abdul El-Sayed in the Democratic US Senate primary in Michigan "makes it really challenging as a general election seat for Democrats to flip," and looks at how the US economy plays into the midterm elections.
Matt McLennan, First Eagle Investments Head of Global Value Team, joins Bloomberg's Vonnie Quinn on "Bloomberg Brief" to discuss the market complacency created by a high concentration in AI.
Artificial intelligence models developed by OpenAI and Anthropic PBC carried out "unsanctioned" actions including hacking a website and attempting to inject harmful code into software during safety testing reinforcing fears that neither the creators nor seasoned researchers of these systems can predict their actions in testing. Bloomberg Opinion columnist Parmy Olson joins Francine Lacqua on "The Pulse" to discuss the implications.
Dan Ives, partner and senior managing director at Yorkville Ives & Co., examines the first quarterly report from SpaceX as the company disclosed higher-than-expected spending on its artificial intelligence business.
Novo Nordisk Chief Executive Officer Mike Doustdar says the profitability of its popular Wegovy weight-loss pill is "decent" and will continue to improve. "If that was not the case, we would not be launching the product in more and more markets," he tells Bloomberg Television.
Novo Nordisk A/S Chief Executive Officer Mike Doustdar talks about the company's performance as its popular Wegovy weight-loss pill disappointed investors with sales that failed to live up to the hype. "We are not right now discussing further discounts," Doustdar tells Bloomberg's Francine Lacqua.
Anna Edwards, Lizzy Burden and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."
GET YOUR GRAFA EDGE NOW
Sign up free to unlock this feature
We'll switch on a 30-day Edge trial as a welcome gift
